Johnson & Johnson
Johnson & Johnson Vision is a global leader in eye health, focused on helping people see better and live fuller lives. The company offers a wide range of advanced eye care products and continues to invest in new ideas and technology. In myopia management, Johnson & Johnson Vision develops treatments designed to slow the progression of myopia in children. Their commitment to eye care shows their dedication to improving vision and making a lasting difference for people around the world.
Johnson & Johnson myopia management products
Myopia management products listed by Myopia Profile have been specifically designed for myopia control or myopia management in children, and have some form of regulatory approval or marking for this form of use. They also have randomized controlled trial research data supporting their efficacy, unless otherwise noted. It is up to the individual eye care practitioner to be aware of regulatory requirements for prescribing in their country of practice, and also be aware that not all products are available in all countries.
Abiliti™ 1-Day
Abiliti™ 1-Day are soft contact lenses designed to slow the progression of myopia in children. They use RingBoost™ technology to maintain clear vision while delivering strong treatment power. Abiliti™ 1-Day lenses may become a first-choice option for managing progressive myopia in children. Early results from a clinical trial, with six months of data published so far, show promising outcomes.
Abiliti™ Overnight Therapeutic Lenses
Abiliti™ Overnight orthokeratology lenses give eye care professionals a first-line option for managing myopia in children. With the support of FitAbiliti™ software, lenses can be fitted more easily and accurately through a streamlined process. The system’s feedback helps more practitioners adopt orthokeratology as part of their myopia management toolkit. Abiliti™ Overnight lenses are available in two designs, one for spherical corrections and one for myopia with astigmatism. Orthokeratology has a strong evidence base, making it a trusted treatment for children with myopia.